Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,657 Endocrine
clinical trials

Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
569
mi
from
Houston, TX
Click here to add this to my saved trials
Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 12/31/1969
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford University School of Medicine
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Methodist Research Institute
572
mi
from
Houston, TX
Click here to add this to my saved trials
Pre-Diabetes Clinical Trial
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
Status: Enrolling, Phase I
Updated: 1/12/2016
VA San Diego Healthcare System
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis Clinical Trial
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status: Enrolling, Phase IV
Updated: 12/31/1969
Brookview Hills Research Associates, LLC
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Metabolic Syndrome and Fall Risk
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Status: Enrolling
Updated: 1/18/2018
Center for Research in Reproduction
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Insulin Sensitivity/Resistance Clinical Trial
Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity
Status: Enrolling
Updated: 12/31/1969
University of Texas at El Paso
642
mi
from
El Paso, TX
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
Hereditary Risk Factors for Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
The Effects of Bariatric Surgeries on Glucose Metabolism
Status: Enrolling, Phase
Updated: 12/31/1969
South Texas Veterans Health Care System
571
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Replacing Refined Carbohydrates With Healthy Fats on Cardio-metabolic Markers
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology Clinical Trial
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
Status: Enrolling
Updated: 4/6/2018
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Vermont College of Medicine
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Virginia Cancer Center
1051
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Rainbow Babies and Children's Hospital
899
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Orange County
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
C S Mott Children's Hospital
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolinas Medical Center / Levine Cancer Institute
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne State University/Karmanos Cancer Institute
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Physician Group-Effingham
510
mi
from
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
El Paso Children's Hospital
639
mi
from
El Paso, TX
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Fontana
1125
mi
from
Fontana, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
East Carolina University
1139
mi
from
Greenville, NC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Francis Cancer Center
885
mi
from
Greenville, SC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Iowa - Holden Comprehensive Cancer Center
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
East Tennessee Children's Hospital
778
mi
from
Knoxville, TN
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Morristown Medical Center
1262
mi
from
Morristown, NJ
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of New Orleans
696
mi
from
New Orleans, LA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Hospital Orlando
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Lucile Packard Children's Hospital Stanford University
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Barnes Jewish Hospital
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-San Diego Mission
1140
mi
from
San Diego, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Seattle Children's Hospital
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
1201
mi
from
Spokane, WA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
State University of New York Upstate Medical University
1197
mi
from
Syracuse, NY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Childrens National Medical Center
1127
mi
from
Washington DC,
Click here to add this to my saved trials
Thyroid Eye Disease Clinical Trial
Celecoxib for Thyroid Eye Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Wilmer Eye Institute, Johns Hopkins University
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypothyroidism;Postablative Clinical Trial
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Status: Enrolling, Phase IV
Updated: 12/31/1969
Diabetes & Endocrinology Consultants
1189
mi
from
Morehead City, NC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Cushing Syndrome Clinical Trial
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Cushing Syndrome Clinical Trial
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Joseph's Hospital and Medical Center
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Glycogen Storage Disease Type II Clinical Trial
Respiratory Muscle Training in L-Onset Pompe Disease (LOPD)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Columbia University
1290
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwestern University
613
mi
from
Evanston, IL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Charlotte Heart Group Research Center
1178
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Washington University
413
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Wake Forest University
974
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Endocrinology, Oncology, Other Clinical Trial
Wound Complications in Head and Neck Surgery
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Obesity Clinical Trial
Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Musculoskeletal Clinical Trial
Outcomes Study of MTM in a Medicare ACO
Status: Enrolling
Updated: 6/1/2017
HealthEast Care System
553
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Endocrinology Clinical Trial
Brown Fat Activation Study
Status: Enrolling, Phase
Updated: 12/31/1969
Center for Clinical and Translational Science
725
mi
from
Lexington, KY
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Lehigh Valley Health Network
1210
mi
from
Allentown, PA
Click here to add this to my saved trials
Lymphangioleiomyomatosis Clinical Trial
Discovery of Sirolimus Sensitive Biomarkers in Blood
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Status: Enrolling, Phase IV
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
1048
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Status: Enrolling, Phase IV
Updated: 12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University School of Medicine
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Chicago Medicine
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Vanderbilt University School of Medicine
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Oregon Health & Science University (OHSU)
1384
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente - Sacramento
1283
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente-San Francisco
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Indeterminate Thyroid Cytology Clinical Trial
Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules
Status: Enrolling
Updated: 10/24/2017
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Bioenergetics and Metabolism in Pediatric Populations
Status: Enrolling, Phase
Updated: 4/9/2018
Arkansas Children's Hospital
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
Heart Failure Clinical Trial
Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
801
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lenvatinib and Pembrolizumab in DTC
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lenvatinib and Pembrolizumab in DTC
Status: Enrolling, Phase II
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Associates of Tidewater
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Renstar Medical Research
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Clinical Trials
1046
mi
from
Boise, ID
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
San Diego Sexual Medicine
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Quality of Life Medical & Research Centers, LLC
830
mi
from
Tucson, AZ
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
The Center for Pharmaceutical Research
192
mi
from
Kansas City, KS
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Nevada, LLC
957
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Rainier Clinical Research Center Inc.
1401
mi
from
Renton, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Mayo AVC Registry and Biobank
Status: Enrolling, Phase
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Metabolic Response to Reduced Branched-chain Amino Acids in Humans
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin - Madison, School of Medicine and Public Health
575
mi
from
Madison, WI
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Day and Night Closed-loop in Young People With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver School of Medicine Barbara Davis Center
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Day and Night Closed-loop in Young People With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Yale University
1357
mi
from
Hartford, CT
Click here to add this to my saved trials
Prediabetes Clinical Trial
Preventing Diabetes With Digital Health and Coaching
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Type 1 Diabetes Mellitus With Hypoglycemia Clinical Trial
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California, San Diego
1118
mi
from
San Diego, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Joslin Diabetes Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Burke Internal Medicine And Research
1114
mi
from
Burke, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbus Regional Research Institute
807
mi
from
Columbus, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Mountain View Clinical Research
888
mi
from
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Kentucky Diabetes Endocrinology Center
724
mi
from
Lexington, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Academic Medical Research Institute
1164
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
South Carolina Nephrology & Hypertension Center
995
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Lymphangioleiomyomatosis Clinical Trial
LAM Pilot Study With Imatinib Mesylate
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University
1290
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Impact of NMES and HPRO on Recovery After SAH
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Adult-Onset Growth Hormone Deficiency Clinical Trial
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
Status: Enrolling
Updated: 2/13/2018
VA Puget Sound Health Care System
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Valued EpiGenetic Glycemic ImprovEments Through Weight Loss
Status: Enrolling
Updated: 12/31/1969
Wake Forest Health Sciences
979
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Endocrinology Clinical Trial
Exercise and Insulin Signaling in Human Skeletal Muscle
Status: Enrolling
Updated: 4/4/2018
Oregon State University
1398
mi
from
Corvallis, OR
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 … 37